Investor & Advisor Contacts

Registered and Head Office: Clinical Sciences Building
City Hospital
Hucknall Road
Nottingham NG5 1PB
Company Secretary: Andrew Millet
Nominated AdviserZeus Capital Limited
10 Old Burlington Street
London W1S 3AG


82 King Street
Manchester M2 4WQ
Joint BrokersBerenberg
60 Threadneedle Street
London EC2R 8HP

Bryan Garnier & Co
Beaufort House, 15 St Botolph Street
London EC3A 7BB

Zeus Capital Limited
10 Old Burlington Street
London W1S 3AG
Reporting Accountants: Grant Thornton UK LLP
101 Cambridge Science Park
Milton Road
Cambridge CB4 0FY
Solicitors to the Company: Peachey & Co LLP
95 Aldwych
London WC2B 4JF
Patent Attorneys to the Company:Boult Wade Tennant
Verulam Gardens
70 Gray’s Inn Road
London WC1X 8BT
Legal advisers to the Nominated Adviser and Broker:K&L Gates LLP
One New Change
London EC4M 9AF
Financial PR: Consilium Strategic Communications Limited
41 Lothbury
London EC2R 7HG
Company Registrars:Link Asset Services
34 Beckenham Road
Kent BR3 4TU


Electronic versions of the materials you are seeking to access are being made available on this website by Oncimmune Holdings plc (the “Company”).

These materials are not directed to nor are they intended for access by persons located or resident in the United States, Australia, Canada, South Africa, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

None of the securities of Company discussed or referred to in the materials you are seeking to access have been registered under the US Securities Act or 1933, as amended (the “Securities Act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of Rule 903 or Rule 904 of Regulation S under the Securities Act, (2) pursuant to an effective registration statement under the Securities Act, or (3) pursuant to an available exemption from the registration requirements of the Securities Act, in each case in accordance with all applicable securities laws.

By clicking the “SUBMIT” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the United States and do not have a registered address in, and are not resident or located in, Australia, Canada, South Africa or Japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website.

Please click on the button below to confirm that you have read, understood and agree with the disclaimer above.

Yes, I accept No, I don't accept